Lorenzo A, Razzaboni B, Weir GC, Yankner BA (1994). "Pancreatic islet cell toxicity of amylin associated with type-2 diabetes mellitus". Nature368 (6473): 756–60. PMID8152488. doi:10.1038/368756a0.
Lim YA, Rhein V, Baysang G, Meier F, Poljak A, Raftery MJ, Guilhaus M, Ittner LM, Eckert A, Götz J. (2010). "Abeta and human amylin share a common toxicity pathway via mitochondrial dysfunction". Proteomics10 (8): 1621–33. PMID20186753. doi:10.1002/pmic.200900651.
Pittner RA, Albrandt K, Beaumont K; et al. (1994). "Molecular physiology of amylin". J. Cell. Biochem. 55 Suppl: 19–28. PMID7929615. doi:10.1002/jcb.240550004.
Brender JR, Lee EL, Cavitt MA, Gafni A, Steel DG, Ramamoorthy A (2008). "Amyloid fiber formation and membrane disruption are separate processes localized in two distinct regions of IAPP, the type-2-diabetes-related peptide". J. Am. Chem. Soc.130 (20): 6424–9. PMID18444645. doi:10.1021/ja710484d.
Shen Y, Joachimiak A, Rosner MR, Tang WJ (2006). "Structures of human insulin-degrading enzyme reveal a new substrate recognition mechanism". Nature443 (7113): 870–4. PMID17051221. doi:10.1038/nature05143.
Hay DL, Christopoulos G, Christopoulos A, Sexton PM (2004). "Amylin receptors: molecular composition and pharmacology". Biochem Soc Trans32 (5): 865–7. PMID15494035. doi:10.1042/BST0320865.
Hayden MR (2002). "Islet amyloid, metabolic syndrome, and the natural progressive history of type 2 diabetes mellitus". JOP3 (5): 126–38. PMID12221327.
Lorenzo A, Razzaboni B, Weir GC, Yankner BA (1994). "Pancreatic islet cell toxicity of amylin associated with type-2 diabetes mellitus". Nature368 (6473): 756–60. PMID8152488. doi:10.1038/368756a0.
Lim YA, Rhein V, Baysang G, Meier F, Poljak A, Raftery MJ, Guilhaus M, Ittner LM, Eckert A, Götz J. (2010). "Abeta and human amylin share a common toxicity pathway via mitochondrial dysfunction". Proteomics10 (8): 1621–33. PMID20186753. doi:10.1002/pmic.200900651.
Pittner RA, Albrandt K, Beaumont K; et al. (1994). "Molecular physiology of amylin". J. Cell. Biochem. 55 Suppl: 19–28. PMID7929615. doi:10.1002/jcb.240550004.
Brender JR, Lee EL, Cavitt MA, Gafni A, Steel DG, Ramamoorthy A (2008). "Amyloid fiber formation and membrane disruption are separate processes localized in two distinct regions of IAPP, the type-2-diabetes-related peptide". J. Am. Chem. Soc.130 (20): 6424–9. PMID18444645. doi:10.1021/ja710484d.
Shen Y, Joachimiak A, Rosner MR, Tang WJ (2006). "Structures of human insulin-degrading enzyme reveal a new substrate recognition mechanism". Nature443 (7113): 870–4. PMID17051221. doi:10.1038/nature05143.
Hay DL, Christopoulos G, Christopoulos A, Sexton PM (2004). "Amylin receptors: molecular composition and pharmacology". Biochem Soc Trans32 (5): 865–7. PMID15494035. doi:10.1042/BST0320865.